Testosterone Replacement May Lower Death Rate Among Type 2 Men

7140

By: Diabetes Health Staff

British researchers say that testosterone replacement therapy for type 2 men with low testosterone levels could reduce their death rate significantly. Over the course of a six-year study by the University of Sheffield, only 8.6 percent of low-testosterone subjects who were given replacement therapy died, compared to 20 percent of low-testosterone subjects who did not receive the therapy.  

The study involved 587 type 2 men who were divided into three groups:
• Men with normal testosterone levels (Nine percent of this group died over the course of the study)
• Men with low testosterone levels who were not treated with replacement therapy (20 percent of this group died over the course of the study)
• Men with low testosterone levels who received replacement therapy (8.6 percent of this group died over the course of the study, slightly fewer than in the normal testosterone-level group)

The study results confirm a suspicion that low testosterone levels, which occur in many men with type 2 diabetes, can be linked to an increased risk of death. However, these results also suggest that it may be possible to offer a fairly simple treatment to counter that risk. Further studies on a larger scale will be needed to confirm the findings.

The researchers presented their findings in early April at the Society for Endocrinology BES 2011 meeting in Birmingham, UK.

Comments

comments

Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.